CLOs on the Move

Hunt Memorial Hospital District

www.hmhd.org

 
March 6, 2006 - As the Hunt Memorial Hospital District continues to develop the final plans for the new Cancer Center, Presbyterian Hospital of Greenville is keeping sight of the softer side of patient care.
  • Number of Employees: 0-25
  • Annual Revenue: $100-250 Million
  • www.hmhd.org
  • 4215 Joe Ramsey Blvd E
    Greenville, TX USA 75401-7852
  • Phone: 903.408.5000

Executives

Name Title Contact Details

Similar Companies

Pacific Island Medical Inc

Pacific Island Medical Inc is a Kailua, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aprecia

Aprecia, The 3DP Pharmaceutical Company, expects to use its ZipDose® Technology to transform the way people take medicine. Its first innovation, ZipDose Technology can be combined with a wide variety of active pharmaceutical ingredients to create rapidly disintegrating oral dosage forms that are easy to take and easy to administer. Aprecia is committed to enhancing the patient experience through novel approaches to drug delivery that address unmet treatment needs to eliminate patient suffering and caregiver burden.

Community Interface Services

Community Interface Services is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Infectio Diagnostic (I.D. L)

Infectio Diagnostic (I.D. L), Inc. is a Quí©bec, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

NeuroPace

The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world`s first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company`s initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.